Search
ACADIA Pharmaceuticals Inc
ACADAdd to Watchlist
21.620USD
+0.020+0.09%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.70BMarket Cap
9.70P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q2
FY2023Q1
By BusinessUSD
Name
Revenue
Proportion
NUPLAZID
680.09M
63.47%
DAYBUE
391.42M
36.53%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
NUPLAZID
680.09M
63.47%
DAYBUE
391.42M
36.53%
